Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy [Phase 2]

View source ↗

Summary

This Phase 2 trial evaluated combination chemotherapy plus filgrastim in patients with stage IV prostate cancer that progressed after hormone therapy. The study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Filgrastim (filgrastim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED